[go: up one dir, main page]

(Q46027013)

English

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

scientific article published on 24 March 2009

  • The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation
In more languages
default for all languages
No label defined

No description defined

Statements

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit